Certification Rate
90%
Moderate DOL cert
A DOL Labor Condition Application record spanning FY2023–2025. Review the filing volume, DOL certification record, and offered-wage context below.
New York, NY NAICS: 54171
U.S. Department of Labor's OFLC discloses 10 Labor Condition Application filings naming Stemline Therapeutics, Inc. from FY2023 through FY2025, drawn directly from DOL's quarterly public disclosure releases. An LCA is the wage-and-working-conditions attestation an employer files with DOL before petitioning USCIS for an H-1B worker: it is a filing record, not a USCIS approval, a job offer, or a confirmed hire, and the count reflects filings, not people, since an employer sponsoring the same role at more than one worksite, or refiling across fiscal years, is counted once per filing. See filing history · Recent LCAs
Separate from the DOL filing record above, U.S. Citizenship and Immigration Services adjudicated 9 H-1B petitions naming Stemline Therapeutics, Inc. through FY2024, and approved nearly every one of them: 100% approved (9 approvals, 0 denials). A DOL certification is the labor-condition step filed before a petition; this USCIS figure is the actual adjudicated outcome, and the two rates commonly differ.
The verdict
Stemline Therapeutics, Inc. is listed in 10 DOL LCA filings, more filings than 85% of employer filers in this extract. DOL certified 90% of those LCAs; the median listed offered wage is $223,298. This is not a USCIS approval, hiring, or sponsorship ranking.
According to U.S. Department of Labor OFLC LCA disclosure files (FY2023–FY2025). Based in New York, NY.
Stemline Therapeutics, Inc. LCA outcome mix
10DOL LCA filings on record
Stemline Therapeutics, Inc. vs all U.S. employer filers by LCA volume
Where this employer's disclosed Labor Condition Application count sits among every tracked employer filer (inventory signal, not a sponsorship ranking)
10 19168th of 122824 higher than 103,656 of 122,824 employer filers
Employer filers, banded by disclosed H-1B LCA filing count
Each bar is a band; taller bars hold more employer filers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source U.S. Department of Labor OFLC · FY2023–FY2025
Derived from this employer's disclosed LCAs on file (FY2023–FY2025), title mix and worksite counties, not national boilerplate. LCA filings do not establish USCIS outcomes or confirmed hiring.
Offered-wage span on file: $118,052–$326,000 .
On 10 LCAs with comparable offered vs prevailing wages, Stemline Therapeutics, Inc. averages about 41.6% above the prevailing wage (national baseline ≈ 17.8%). Dominant PW level on file: Fully Competent (Level IV) (60% of LCA filings).
Only 10 LCAs on file for Stemline Therapeutics, Inc., and 70% land in NEW YORK, NY. Treat rates as descriptive of a small sample. DOL cert on file: 90%.
Certification Rate
90%
Moderate DOL cert
Avg. Salary
$223,298
Well above portal avg
Total Workers
10
Small worker count
Compensation range for H-1B positions at Stemline Therapeutics, Inc.
Wage vs. DOL Minimum
+41.6%
High vs DOL floor
national avg +17.8%
Typical DOL Wage Level
Fully Competent (Level IV)
60% of LCA filings
Full-Time Positions
100%
Primary Worksite County
NEW YORK, NY
70% of LCA filings
Most frequently listed job titles at Stemline Therapeutics, Inc.
| Job Title | LCA filings | Avg. Salary |
|---|---|---|
| AVP, Commercial Excellence Analytics | 4 | $318,000 |
| Sr. Manager, R&D | 2 | $158,963 |
| Associate Director, Data Strategy & Omnichannel Enablement | 2 | $175,000 |
| Sr. Manager, Commercial Applications | 1 | $175,000 |
| Global Regulatory Affairs Manager | 1 | $118,052 |
Cross-state DOL neighbors for Stemline Therapeutics, Inc. - LCA filing-count and offered-wage axes, outside NY.
Nearest cross-state employer filers by LCA filing count (10 here; floor ≥10 LCA filings).
Cross-state employer filers with a comparable average listed offered wage ($223,298 here).
Stemline Therapeutics, Inc. is listed in 10 DOL Labor Condition Application filings covering 10 listed worker positions from FY2023 to FY2025. An LCA is a Labor Department filing record, not confirmation of a USCIS petition, hire, sponsorship, or visa approval.
Among 122,824 employer filers in the DOL disclosure extract, Stemline Therapeutics, Inc. ranks #17821 by total LCA filing count (10 filings). 103,656 employer filers have fewer disclosed filings in this extract. This is a filing-volume comparison only, not a USCIS approval, hiring, or sponsorship ranking.
Stemline Therapeutics, Inc. has a 90% DOL certification rate, with 9 out of 10 LCA filings certified. That is the Labor Department step, not a USCIS visa approval rate.
The average offered wage listed in Stemline Therapeutics, Inc.'s LCAs is $223,298. Listed wages range from $118,052 to $326,000 and are not verified actual compensation.
The top job titles in Stemline Therapeutics, Inc.'s LCA filing records include AVP, Commercial Excellence Analytics, Sr. Manager, R&D, Associate Director, Data Strategy & Omnichannel Enablement. The most common listed title is AVP, Commercial Excellence Analytics with 4 LCA filings at an average listed offered wage of $318,000. This does not establish actual job openings, hiring, or approved petitions.
Stemline Therapeutics, Inc. is headquartered in New York, NY. Their H-1B workers are distributed across 2 states, with the most positions in NY, NJ.
No, Stemline Therapeutics, Inc. is not classified as H-1B dependent.
Stemline Therapeutics, Inc. is listed in 4 LCA filings in FY2023 and 3 in FY2025. The average listed offered wage increased from $234,482 to $275,667. This historical filing series does not predict sponsorship, hiring, or visa outcomes.
Disclaimer: Informational only, not professional advice.
ABS(total_petitions) peers first, then a LARGEST-distance pole and a stamp-branched drill, not a fixed Related strip. This page stamps MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 10 LCAs (Δ 0 heavier vs Stemline Therapeutics, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 10 LCAs (Δ 0 heavier vs Stemline Therapeutics, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 10 LCAs (Δ 0 heavier vs Stemline Therapeutics, Inc.); CERT-LOCK · WAGE-ELITE vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
ABS(total_petitions) peer at 10 LCAs (Δ 0 heavier vs Stemline Therapeutics, Inc.); CERT-LOCK · WAGE-PREMIUM vs this page's MICRO-BOOK · CERT-SOLID · WAGE-ELITE.
NY pole at 6,144 LCAs stamps HEAVY-BOOK · CERT-LOCK, farthest ABS(total_petitions) contrast from Stemline Therapeutics, Inc.'s MICRO-BOOK.
Open the NY state board after the ABS peers. Stemline Therapeutics, Inc. stamps MICRO-BOOK · CERT-SOLID inside that worksite mix.
Stemline Therapeutics, Inc.'s CERT-SOLID stamp sits below CERT-CLEAN. Start with how LCA certification works.
What to do with this profile
Use the DOL LCA record for Stemline Therapeutics, Inc. to compare filing volume and offered wages, not USCIS outcomes.
DOL disclosure data only. Not legal advice, sponsorship guarantees, or visa eligibility.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error. Data current as of 2026-09-09.